Pill Identifier Ranolazine - NDC 50228-423
Ranolazine
Product Code 50228-423
Ranolazine by Sciegen Pharmaceuticals, Inc is a orange oval tablet film coated extended release about 17 mm in size, imprinted with sg;423. The product is a human prescription drug with active ingredient(s) ranolazine.
Ranolazine
Active Ingredient(s): Ranolazine
Inactive Ingredient(s):
- MICROCRYSTALLINE CELLULOSE
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
- SODIUM LAURYL SULFATE
- POLYSORBATE 80
- HYPROMELLOSE, UNSPECIFIED
- SODIUM HYDROXIDE
- MAGNESIUM STEARATE
- HYPROMELLOSE 2910 (15 MPA.S)
- TITANIUM DIOXIDE
- LACTOSE MONOHYDRATE
- POLYETHYLENE GLYCOL, UNSPECIFIED
- TRIACETIN
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
Sciegen Pharmaceuticals, Inc
Product Type: Human Prescription Drug
Dosage Form: Tablet, Film Coated, Extended Release
- Orange (C48331)
Product Packages
NDC Package Code | Package Description |
---|---|
50228-423-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE |
50228-423-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE |
50228-423-60 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.